BioSpace News Archive

Biologics by McKesson continues to expand its capabilities as a specialty pharmacy expert in oncology and complex conditions through a new exclusive distribution agreement

Goals of Care Coalition of New Jersey (GOCCNJ) has launched a new educational program to improve end-of-life care among minority patient populations in New Jersey

Clinical interventions provided by a nutrition support team can prevent hospital readmission in patients with short bowel syndrome receiving home parenteral nutrition, saving millions in costs annually, suggests a study¹ by Option Care Enterprises, Inc., the nation’s leading provider of home and alternate site infusion therapy services.

Mirroring the quick-paced nature of new technological innovations, the surgical robotics market has experienced significant prosperity recently, which is expected to continue through 2025.

Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million Series B financing led by Omega Funds, a leading international investment firm that creates and invests in life sciences companies.

Samsung BioLogics is pleased to announce that Samsung has won CMO Leadership Awards for all six core categories for the third year in a row in the 8th annual CMO Leadership Awards Reception presented by Life Science Leader.

Orexo’s Annual Report, including the Sustainability Report, for the 2018 fiscal year has been published and can be downloaded on the company’s website, www.orexo.com.

CRISPR and Synthetic Biology Platforms SHERLOCKTM and INSPECTRTM Hold Potential to Disrupt Diagnostics

Women’s health company offers new training facility for partners, healthcare professionals and employees

Oragenics, Inc. announced the pricing of its previously announced underwritten public offering of 16,666,668 shares of common stock, short-term warrants to purchase up to 8,333,334 shares of common stock, and long-term warrants to purchase up to 8,333,334 shares of common stock, at a price to the public of $0.75 per share and accompanying warrants.